MALIGNANT MESOTHELIOMA

Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT MESOTHELIOMA trials appear

Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3 Terminated 1

New Dual-Action antibody takes on advanced cancers

Disease control Ongoing

This early-phase study tests a new drug called SI-B003 in 60 people with advanced solid tumors that have spread or come back. The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goals are to find a safe dose and check for side effect…

Matched conditions: MALIGNANT MESOTHELIOMA

Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

MALIGNANT MESOTHELIOMA

Get alerted when new MALIGNANT MESOTHELIOMA trials appear

New Dual-Action antibody takes on advanced cancers